Allograft

AlloSource Releases AlloFuse Line Extentsion

Company adds AlloFuse Select CM, a cellular allograft matrix, to the AlloFuse portfolio Centennial, Colo. — August 1, 2017 — AlloSource, one of the nation’s largest providers of cartilage, bone, skin, soft-tissue, and cellular allografts to advance patient healing in surgical procedures and wound care, today announced the release of AlloFuse® Select CM, a premium addition to AlloSource’s AlloFuse portfolio. AlloFuse Select CM combines osteoconductive, osteoinductive, and osteogenic properties to initiate and nurture bone growth, delivering the benefits of autograft bone without the potential drawbacks. The product is clinically proven to activate and support bone formation and can be used…

AlloSource’s Burn Skin AlloGraft Rebranded To Pureskin

Company to feature PureSkin at the American Burn Association Annual Meeting Centennial, Colo. — March 20, 2017 — AlloSource, one of the nation’s largest providers of burn skin, cartilage, bone, soft-tissue and cellular allografts for use in surgical procedures and burn and wound care to advance patient healing, will feature its PureSkin™ human skin allograft at the 49th American Burn Association Annual Meeting. AlloSource has been a longtime leader in providing skin allografts to help patients heal from burns, and its rebranded PureSkin allograft offers clinicians a temporary biological dressing for burn patients. The product is available in both cryopreserved…